Rockwell Medical Inc.

(RMTI) Trade

By |

Profile

Rockwell Medical Inc is a US-based fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, and hemodialysis. The company's drug products are Triferic and Calcitriol. Triferic is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients with chronic kidney disease. Calcitriol is a generic drug for treating secondary hyperparathyroidism in dialysis patients. The company operates in one segment of the hemodialysis market which involves the manufacture, sale, and distribution of hemodialysis products. The majority of the revenue is generated form the United States.

Contact Information

Website: www.rockwellmed.com
Email: invest@rockwellmed.com
Main Phone: +1 248 960-9009
Address: 411 Hackensack Avenue
Address 2: Suite 501
State: NJ
City / Town: Hackensack
Country: USA
Postal Code: 07601

Issuer Information

Exchange: NSD
CEO: Russell H. Ellison
Employees: 299
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Rockwell Medical Inc is a US-based fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, and hemodialysis. The company's drug products are Triferic and Calcitriol. Triferic is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients with chronic kidney disease. Calcitriol is a generic drug for treating secondary hyperparathyroidism in dialysis patients. The company operates in one segment of the hemodialysis market which involves the manufacture, sale, and distribution of hemodialysis products. The majority of the revenue is generated form the United States.

Contact Information

Website: www.rockwellmed.com
Email: invest@rockwellmed.com
Main Phone: +1 248 960-9009
Address: 411 Hackensack Avenue
Address 2: Suite 501
State: NJ
City / Town: Hackensack
Country: USA
Postal Code: 07601

Issuer Information

Exchange: NSD
CEO: Russell H. Ellison
Employees: 299
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 2.14 $ 0. (0.00%)
Last Price 2.14 Change $ 0. Change % 0.00 Tick N/A
Bid 2.05 Bid Size 400.00 Ask 2.17 Ask Size 1,500.00
Open 2.16 High 2.18 Low 2.08 Prev Close 2.14
Last Trade Volume 356,082 52 Wk Hi 4.70 52 Wk Low 1.31
Market Cap 147.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 69,069,078.00 EPS (TTM) -0.53 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 20
Number of Buys 0 10
Number of Sells 0 10
Net Activity 0 -304794
Last 10 Buys Shares
David S. Richmond 1,000
David S. Richmond 1,000
David S. Richmond 1,000
David S. Richmond 1,000
David S. Richmond 1,000
Robert L. Chioini 1,000
Ajay Gupta 1,000
Ajay Gupta 1,000
Robert L. Chioini 1,000
Robert L. Chioini 1,000
Last 10 Sell Shares
David S. Richmond 1,000
Kenneth L. Holt 1,000
Kenneth L. Holt 1,000
Kenneth L. Holt 1,000
Kenneth L. Holt 1,000
Kenneth L. Holt 1,000
Kenneth L. Holt 1,000
Kenneth L. Holt 1,000
Kenneth L. Holt 1,000
Kenneth L. Holt 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 6.5 6.5 6.5 6.5
Low Target Price Estimate 2 2 2 2
Mean Target Price Estimate 4.25 4.25 4.25 4.25
Standard Deviation 3.18 3.18 3.18 3.18
Date of Most Recent Estimate 03/16/18 03/16/18 03/16/18 03/16/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.65 2.65 2.65 2.65